Huffpost Business

Pfizer Earnings 2011: Drug Giant Beats Profit, Sales Forecasts

Posted: Updated:
Pfizer beat forecasts for its sales and profits, according to the drug giant's latest earnings report. | Getty

Pfizer Inc reported better-than-expected quarterly results, helped by sales growth of its prescription drugs in emerging markets and its animal health, nutritionals and consumer healthcare products.

The world's biggest drugmaker said on Tuesday it earned $3.74 billion, or 48 cents per share in the third quarter, including a $1.3 billion after-tax gain on the recent sale of its Capsugel business.

That compared with a profit of $866 million, or 11 cents per share, in the year-earlier period, when the company took a big charge for asbestos litigation.

Excluding special items, Pfizer earned 62 cents per share. Analysts on average expected 56 cents per share, according to Thomson Reuters I/B/E/S.

Global revenue rose 7 percent to $17.19 billion, well above Wall Street expectations of $16.42 billion.

(Reporting by Ransdell Pierson; Editing by Derek Caney)

Copyright 2011 Thomson Reuters. Click for Restrictions.

Around the Web

Pfizer's CEO Discusses Q2 2011 Results - Earnings Call Transcript ...

PFIZER INC (PFE:New York): Earnings Estimates - BusinessWeek

Pfizer Earnings: Pfizer Earnings, Sales Slide but Edge Street ...

Q2 2011 Pfizer Inc Earnings Conference Call on Aug. 02. 2011 / 2 ...

Company Earnings |

Pharma Earnings Winner: Pfizer Versus Merck (MRK, PFE, LLY) - 24 ...

A.M. Vitals: Pfizer Earnings Rise 5.5% in Second Quarter - Health ...

Pfizer Inc. Third Quarter Earnings on the Horizon - Yahoo! Finance

Pfizer Inc PFE Q2 2011 Earnings Call Transcript